Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Net Asset Quality Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Net Asset Quality Index of 72.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.22 Billion minus total liabilities of CN¥2.85 Billion yields net assets of CN¥7.37 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Zhejiang CONBA Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhejiang CONBA Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2001–2025)
This chart shows how Zhejiang CONBA Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 25 annual periods from 2001 to 2025. As of March 2026, the index stands at 72.1%, representing net assets of CN¥7.37 Billion against total assets of CN¥10.22 Billion CNY. Explore Zhejiang CONBA Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd (2001–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Zhejiang CONBA Pharmaceutical Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.6% | CN¥7.15 Billion | CN¥9.98 Billion | CN¥2.83 Billion | ▲ +1.8 pp |
| 2024 | 69.8% | CN¥6.91 Billion | CN¥9.90 Billion | CN¥2.99 Billion | ▲ +4.4 pp |
| 2023 | 65.4% | CN¥7.35 Billion | CN¥11.24 Billion | CN¥3.89 Billion | ▼ -1.6 pp |
| 2022 | 67.0% | CN¥7.32 Billion | CN¥10.93 Billion | CN¥3.61 Billion | ▼ -1.5 pp |
| 2021 | 68.5% | CN¥7.39 Billion | CN¥10.79 Billion | CN¥3.40 Billion | ▲ +10.8 pp |
| 2020 | 57.7% | CN¥5.35 Billion | CN¥9.28 Billion | CN¥3.93 Billion | ▲ +7.5 pp |
| 2019 | 50.1% | CN¥4.94 Billion | CN¥9.86 Billion | CN¥4.92 Billion | ▼ -3.9 pp |
| 2018 | 54.1% | CN¥5.79 Billion | CN¥10.71 Billion | CN¥4.92 Billion | ▼ -8.0 pp |
| 2017 | 62.0% | CN¥5.84 Billion | CN¥9.42 Billion | CN¥3.58 Billion | ▲ +9.2 pp |
| 2016 | 52.8% | CN¥4.49 Billion | CN¥8.50 Billion | CN¥4.01 Billion | ▲ +5.1 pp |
| 2015 | 47.7% | CN¥4.57 Billion | CN¥9.57 Billion | CN¥5.00 Billion | ▼ -5.8 pp |
| 2014 | 53.5% | CN¥3.37 Billion | CN¥6.30 Billion | CN¥2.93 Billion | ▼ -4.7 pp |
| 2013 | 58.2% | CN¥2.59 Billion | CN¥4.45 Billion | CN¥1.86 Billion | ▲ +4.4 pp |
| 2012 | 53.8% | CN¥2.44 Billion | CN¥4.54 Billion | CN¥2.10 Billion | ▼ -0.7 pp |
| 2011 | 54.5% | CN¥1.61 Billion | CN¥2.96 Billion | CN¥1.35 Billion | ▼ -15.2 pp |
| 2010 | 69.7% | CN¥1.72 Billion | CN¥2.46 Billion | CN¥747.34 Million | ▲ +10.2 pp |
| 2009 | 59.5% | CN¥1.15 Billion | CN¥1.93 Billion | CN¥780.76 Million | ▲ +0.9 pp |
| 2008 | 58.6% | CN¥919.66 Million | CN¥1.57 Billion | CN¥649.60 Million | ▲ +3.4 pp |
| 2007 | 55.2% | CN¥854.74 Million | CN¥1.55 Billion | CN¥693.32 Million | ▲ +5.2 pp |
| 2006 | 50.0% | CN¥627.66 Million | CN¥1.26 Billion | CN¥628.20 Million | ▼ -1.5 pp |
| 2005 | 51.5% | CN¥595.08 Million | CN¥1.16 Billion | CN¥560.55 Million | ▼ -6.1 pp |
| 2004 | 57.6% | CN¥565.05 Million | CN¥981.41 Million | CN¥416.37 Million | ▲ +16.4 pp |
| 2003 | 41.2% | CN¥239.44 Million | CN¥581.65 Million | CN¥342.22 Million | ▼ -2.2 pp |
| 2002 | 43.4% | CN¥200.75 Million | CN¥462.63 Million | CN¥261.88 Million | ▲ +2.8 pp |
| 2001 | 40.6% | CN¥181.89 Million | CN¥447.63 Million | CN¥265.74 Million | — |